3.1. Primary AML Cells at the Initial Diagnosis Show Increased Abundance of Several Neutrophil Differentiation Biomarkers Compared with Normal CD34+ Bone Marrow Cells; Results from an Initial Statistical Comparison. This evidence concerns the gene CD34 and acute myeloid leukemia.